Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Viewpoint Collaborates with TriviumVet for Special Educational Episode on Feline Hypertrophic Cardiomyopathy and Pet Wellbeing


News provided by

Viewpoint with host Dennis Quaid

Feb 22, 2024, 03:00 ET

Share this article

Share toX

Share this article

Share toX

TriviumVet
TriviumVet

The educational program highlights a specific condition in cats...

MIAMI, Feb. 22, 2024 /PRNewswire-PRWeb/ -- Renowned actor and host, Dennis Quaid, hosts the program Viewpoint, who have joined forces with TriviumVet to present an enlightening and educational episode centered around Feline Hypertrophic Cardiomyopathy (HCM) and the crucial role of pharmaceutical advancements in enhancing the health of our beloved pets. This special episode not only aims to raise awareness about HCM but also sheds light on the broader significance of pets in our lives.

Feline Hypertrophic Cardiomyopathy is a prevalent heart condition affecting 1 in 7 cats, characterized by thickening of the heart muscles, ultimately leading to compromised heart function. The collaboration between Viewpoint and TriviumVet intends to educate the public about the condition, its diagnosis, treatment options, and the pioneering efforts being made in the field of veterinary pharmaceuticals to combat HCM and similar ailments.

The upcoming episode in partnership with TriviumVet will assemble a panel of distinguished experts in veterinary cardiology and pharmaceutical development as well as owners of HCM cats.

Post this

Hosted by the charismatic Dennis Quaid, Viewpoint has established itself as a platform for insightful conversations and discussions on a wide array of topics. The upcoming episode in partnership with TriviumVet will assemble a panel of distinguished experts in veterinary cardiology and pharmaceutical development as well as owners of HCM cats. These experts will delve into the complexities of HCM, the challenges it poses, and the potential breakthroughs that could revolutionize the way we care for our feline companions.

The episode will also explore the broader context of pets in our lives, emphasizing the profound bond between humans and animals. Pets have consistently proven to be sources of comfort, companionship, and even therapeutic benefits for individuals of all ages. The collaboration between Viewpoint and TriviumVet seeks to underscore the invaluable presence of pets and the responsibility we share in ensuring their well-being, especially new treatments are being researched. Building on the research featured in this episode, 300 cats from across America will be recruited to take part in the larger scale HALT HCM Study. Owners can pre-register interest in the study online at http://www.hcmincats.com

TriviumVet CEO, Louise Grubb comments "We were delighted to be able to shine a light on this exciting breakthrough in Feline Hypertrophic Cardiomyopathy research and we hope this episode encourages cat owners to get their cats screened for HCM and that owners of diagnosed cats might consider enrolling their cat in the HALT HCM study."

Chief Scientific Officer Stuart Fitzgerald comments "Clinical research such as RapaCat and HALT forms the scientific basis to support the approval of new animal medicines. Owners of cats with HCM will be interested in what is coming next: results of the RapaCat study and further research by TriviumVet and others have been submitted to the FDA and are currently under review. We believe the data should support the conditional approval of a new drug for cats with subclinical HCM. We hope that FDA will make a decision on this in the coming months".

Viewpoint and TriviumVet are excited to bring this episode to audiences, fostering awareness, understanding, and dialogue about HCM and the strides being taken in the realm of veterinary medicine. The collaboration aligns with the shared commitment to educate, inform, and empower pet owners and enthusiasts, enabling them to make well-informed decisions for the health and happiness of their furry companions.

About Viewpoint: Viewpoint is an engaging and thought-provoking program hosted by Dennis Quaid, offering insightful discussions on various subjects of interest and significance. With its diverse range of topics, the show provides a platform for experts, thought leaders, and influencers to share their viewpoints and expertise with a global audience.

To watch this episode you can visit Viewpoint on this link.

About TriviumVet: TriviumVet is a pioneer in the field of veterinary pharmaceuticals, dedicated to advancing animal health through innovative research and development. Their focus on cutting-edge solutions for pet ailments, including Feline Hypertrophic Cardiomyopathy, renal disease (CKD), neuropathic pain, and gastrointestinal disease underscores their commitment to enhancing the well-being of pets worldwide.

Media Contact

Development Division, Viewpoint with host Dennis Quaid, 561-244-7620, [email protected], www.viewpointproject.com

SOURCE Viewpoint with host Dennis Quaid

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.